secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001104659-26-008642
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VYNE amends merger with Yarrow to allow pre-funded warrants and beneficial ownership cap
--------------------------------------------------------------------------------

- Amendment allows pre-funded warrants for Yarrow stockholders exceeding 9.99% beneficial ownership limit.
- Parent Pre-Closing Dividend will also be paid to holders of VYNE warrants, per their terms.
- Beneficial ownership limitation per holder set at 0%-19.99%, default 9.99%.
- Amendment signed Jan 30, 2026; merger originally announced Dec 17, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926008642/0001104659-26-008642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926008642/tm264541d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-008642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer